OOIR: Observatory of International Research

Papers

(The H4-Index of Cancer Letters is 61. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)

Article	Citations
Immunotherapy for glioma: Current management and future application	328
Ferroptosis, a novel pharmacological mechanism of anti-cancer drugs	292
Immunotherapy for osteosarcoma: Fundamental mechanism, rationale, and recent breakthroughs	204
CircRNA in cancer: Fundamental mechanism and clinical potential	196
Exosome-encapsulated miRNAs contribute to CXCL12/CXCR4-induced liver metastasis of colorectal cancer by enhancing M2 polarization of macrophages	188
Clinical practice guidelines for the management of adult diffuse gliomas	179
Exosome-transmitted circular RNA hsa_circ_0051443 suppresses hepatocellular carcinoma progression	168
Regulation of Nuclear Factor-KappaB (NF-κB) signaling pathway by non-coding RNAs in cancer: Inhibiting or promoting carcinogenesis?	165
Resveratrol for cancer therapy: Challenges and future perspectives	157
FoxP3+ T regulatory cells in cancer: Prognostic biomarkers and therapeutic targets	156
CAR-NK for tumor immunotherapy: Clinical transformation and future prospects	136
Incidence, mortality, survival, risk factor and screening of colorectal cancer: A comparison among China, Europe, and northern America	133
Advances in the epidemiology of pancreatic cancer: Trends, risk factors, screening, and prognosis	119
Exosomes as potential sources of biomarkers in colorectal cancer	119
Long non-coding RNAs in the doxorubicin resistance of cancer cells	117
RETRACTED: Exosome-mediated transfer of circRNA CircNFIX enhances temozolomide resistance in glioma	106
Triple-negative breast cancer therapeutic resistance: Where is the Achilles' heel?	104
Exosomal miR-1910-3p promotes proliferation, metastasis, and autophagy of breast cancer cells by targeting MTMR3 and activating the NF-κB signaling pathway	100
Hypoxia in tumor microenvironment regulates exosome biogenesis: Molecular mechanisms and translational opportunities	98
Writers, readers and erasers of RNA modifications in cancer	97
Machine Learning in oncology: A clinical appraisal	96
Sonodynamic therapy-derived multimodal synergistic cancer therapy	94
Luteolin and its derivative apigenin suppress the inducible PD-L1 expression to improve anti-tumor immunity in KRAS-mutant lung cancer	90
Pyruvate kinase M2 (PKM2) in cancer and cancer therapeutics	87
Clinical uses of 5-aminolaevulinic acid in photodynamic treatment and photodetection of cancer: A review	86

HPV post-infection microenvironment and cervical cancer	86
Extracellular vesicle packaged LMP1-activated fibroblasts promote tumor progression via autophagy and stroma-tumor metabolism coupling	84
Non-coding RNA in bladder cancer	84
ACSL4 reprograms fatty acid metabolism in hepatocellular carcinoma via c-Myc/SREBP1 pathway	83
Gut microbiota-derived short-chain fatty acids and colorectal cancer: Ready for clinical translation?	83
Phospholipase A2 superfamily in cancer	82
Metabolic adaptation in hypoxia and cancer	81
Biofluid diagnostics by FTIR spectroscopy: A platform technology for cancer detection	81
Translation of noncoding RNAs and cancer	80
METTL3 enhances the stability of MALAT1 with the assistance of HuR via m6A modification and activates NF-κB to promote the malignant progression of IDH-wildtype glioma	80
Hypoxia-induced epithelial to mesenchymal transition in cancer	80
Bone marrow mesenchymal stem cell-derived exosomal miR-206 inhibits osteosarcoma progression by targeting TRA2B	79
Radiotherapy, immunotherapy, and the tumour microenvironment: Turning an immunosuppressive milieu into a therapeutic opportunity	79
CircRNAs in lung cancer - Biogenesis, function and clinical implication	79
LncRNAs in cancer: Regulatory and therapeutic implications	78
Single cell RNA-seq reveals the landscape of tumor and infiltrating immune cells in nasopharyngeal carcinoma	77
The oncogenic and clinical implications of lactate induced immunosuppression in the tumour microenvironment	76
LncRNA-miRNA axes in breast cancer: Novel points of interaction for strategic attack	76
DNA damage response and resistance of cancer stem cells	76
APOBEC: A molecular driver in cervical cancer pathogenesis	75
The CLK inhibitor SM08502 induces anti-tumor activity and reduces Wnt pathway gene expression in gastrointestinal cancer models	73
Cancer-associated fibroblasts induce monocytic myeloid-derived suppressor cell generation via IL-6/exosomal miR-21-activated STAT3 signaling to promote cisplatin resistance in esophageal squamous cell	73
Mitochondrial oxidative stress by Lon-PYCR1 maintains an immunosuppressive tumor microenvironment that promotes cancer progression and metastasis	71
HPV + HNSCC-derived exosomal miR-9 induces macrophage M1 polarization and increases tumor radiosensitivity	69
Epstein–Barr virus-associated gastric cancer: A distinct subtype	69
Cisplatin-stimulated macrophages promote ovarian cancer migration via the CCL20-CCR6 axis	69
Translatable circRNAs and lncRNAs: Driving mechanisms and functions of their translation products	68
Hedgehog transcriptional effector GLI mediates mTOR-Induced PD-L1 expression in gastric cancer organoids	67
Recent advances in strategies for overcoming hypoxia in photodynamic therapy of cancer	66
VCAM-1 secreted from cancer-associated fibroblasts enhances the growth and invasion of lung cancer cells through AKT and MAPK signaling	65
M2 macrophage-derived exosomes promote lung adenocarcinoma progression by delivering miR-942	64
Exosome-mediated delivery of RNA and DNA for gene therapy	64
Imaging of intratumoral heterogeneity in high-grade glioma	62
Exosomes as drug delivery vehicle and contributor of resistance to anticancer drugs	62
Targeting neutrophil extracellular traps with thrombomodulin prevents pancreatic cancer metastasis	61
Exosomal circ_0030167 derived from BM-MSCs inhibits the invasion, migration, proliferation and stemness of pancreatic cancer cells by sponging miR-338-5p and targeting the Wif1/Wnt8/β-catenin axis	61
KLF2 inhibits cancer cell migration and invasion by regulating ferroptosis through GPX4 in clear cell renal cell carcinoma	61